查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1349438

製药 4.0 市场（技术：人工智慧 [AI]、大数据分析、云端运算、物联网 [IoT] 等）- 2023-2031 年全球产业分析、规模、份额、成长、趋势和预测

Pharma 4.0 Market (Technology: Artificial Intelligence [AI], Big Data Analytics, Cloud Computing, Internet of Things [IoT], and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 194 Pages | 商品交期: 2-10个工作天内

价格

製药 4.0 市场 - 报告范围

TMR 关于全球製药 4.0 市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球製药 4.0 市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球製药4.0市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解製药 4.0 市场。

市场概况
2023年市场价值 109 亿美元
2031 年市场价值 469 亿美元
复合年增长率 0.177%

该报告深入探讨了全球製药4.0市场的竞争格局。全球製药 4.0 市场中的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、近期发展和 SWOT 是本报告中介绍的全球製药 4.0 市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 波特五力分析
  • 监管场景
  • 技术进步：药品製造工艺
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依技术分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2017-2031
    • 人工智慧（AI）
    • 大数据分析
    • 云端运算
    • 物联网 (IoT)
    • 其他的
  • 市场吸引力分析：依技术分类

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 药物发现与开发
    • 临床试验
    • 製造业
    • 其他的
  • 市场吸引力分析：按应用

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 製药公司
    • 生技公司
    • CRO 和 CMO
    • 其他的
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Amazon Web Services, Inc.
    • Siemens Healthineers
    • GE Healthcare
    • IBM Corporation
    • Microsoft Corporation
    • Oracle Corporation
    • ABB
    • Honeywell International Inc.
    • Cisco Systems, Inc.
Product Code: TMRGL85095

Pharma 4.0 Market - Scope of Report

TMR's report on the global pharma 4.0 market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global pharma 4.0 market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pharma 4.0 market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pharma 4.0 market.

Market Snapshot
Market Value in 2023US$ 10.9 Bn
Market Value in 2031US$ 46.9 Bn
CAGR17.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pharma 4.0 market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global pharma 4.0 market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pharma 4.0 market.

The report delves into the competitive landscape of the global pharma 4.0 market. Key players operating in the global pharma 4.0 market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pharma 4.0 market profiled in this report.

Key Questions Answered in Global Pharma 4.0 Market Report:

  • What is the sales/revenue generated by pharma 4.0 across all regions during the forecast period?
  • What are the opportunities in the global pharma 4.0 market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Pharma 4.0 Market - Research Objectives and Research Approach

The comprehensive report on the global pharma 4.0 market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pharma 4.0 market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pharma 4.0 market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pharma 4.0 Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pharma 4.0 Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Porter's Five Force Analysis
  • 5.2. Regulatory Scenario Pharma 4.0
  • 5.3. Technological Advancements: Pharmaceutical Manufacturing Processes
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Pharma 4.0 Market Analysis and Forecast, by Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Technology, 2017-2031
    • 6.3.1. Artificial Intelligence (AI)
    • 6.3.2. Big Data Analytics
    • 6.3.3. Cloud computing
    • 6.3.4. Internet of Things (IoT)
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Technology

7. Global Pharma 4.0 Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Drug Discovery and Development
    • 7.3.2. Clinical Trials
    • 7.3.3. Manufacturing
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Pharma 4.0 Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Pharmaceutical Companies
    • 8.3.2. Biotechnology Companies
    • 8.3.3. CROs and CMOs
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Pharma 4.0 Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Pharma 4.0 Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Technology, 2017-2031
    • 10.2.1. Artificial Intelligence (AI)
    • 10.2.2. Big Data Analytics
    • 10.2.3. Cloud computing
    • 10.2.4. Internet of Things (IoT)
    • 10.2.5. Others
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Drug Discovery and Development
    • 10.3.2. Clinical Trials
    • 10.3.3. Manufacturing
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Pharmaceutical Companies
    • 10.4.2. Biotechnology Companies
    • 10.4.3. CROs and CMOs
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Technology
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Pharma 4.0 Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Technology, 2017-2031
    • 11.2.1. Artificial Intelligence (AI)
    • 11.2.2. Big Data Analytics
    • 11.2.3. Cloud computing
    • 11.2.4. Internet of Things (IoT)
    • 11.2.5. Others
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Drug Discovery and Development
    • 11.3.2. Clinical Trials
    • 11.3.3. Manufacturing
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Pharmaceutical Companies
    • 11.4.2. Biotechnology Companies
    • 11.4.3. CROs and CMOs
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Technology
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Pharma 4.0 Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Technology, 2017-2031
    • 12.2.1. Artificial Intelligence (AI)
    • 12.2.2. Big Data Analytics
    • 12.2.3. Cloud computing
    • 12.2.4. Internet of Things (IoT)
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Drug Discovery and Development
    • 12.3.2. Clinical Trials
    • 12.3.3. Manufacturing
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Pharmaceutical Companies
    • 12.4.2. Biotechnology Companies
    • 12.4.3. CROs and CMOs
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Technology
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Pharma 4.0 Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Technology, 2017-2031
    • 13.2.1. Artificial Intelligence (AI)
    • 13.2.2. Big Data Analytics
    • 13.2.3. Cloud computing
    • 13.2.4. Internet of Things (IoT)
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Drug Discovery and Development
    • 13.3.2. Clinical Trials
    • 13.3.3. Manufacturing
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Pharmaceutical Companies
    • 13.4.2. Biotechnology Companies
    • 13.4.3. CROs and CMOs
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Technology
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Pharma 4.0 Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Technology, 2017-2031
    • 14.2.1. Artificial Intelligence (AI)
    • 14.2.2. Big Data Analytics
    • 14.2.3. Cloud computing
    • 14.2.4. Internet of Things (IoT)
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Drug Discovery and Development
    • 14.3.2. Clinical Trials
    • 14.3.3. Manufacturing
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Pharmaceutical Companies
    • 14.4.2. Biotechnology Companies
    • 14.4.3. CROs and CMOs
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Technology
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Amazon Web Services, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Type Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Siemens Healthineers
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Type Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. GE Healthcare
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Type Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. IBM Corporation
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Type Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Microsoft Corporation
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Type Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Oracle Corporation
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Type Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. ABB
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Type Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Honeywell International Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Type Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Cisco Systems, Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Type Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Pharma 4.0 Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 02: Global Pharma 4.0 Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Pharma 4.0 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Pharma 4.0 Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Pharma 4.0 Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Pharma 4.0 Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 07: North America Pharma 4.0 Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Pharma 4.0 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Pharma 4.0 Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 10: Europe Pharma 4.0 Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 11: Europe Pharma 4.0 Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Pharma 4.0 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Pharma 4.0 Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 14: Asia Pacific Pharma 4.0 Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 15: Asia Pacific Pharma 4.0 Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Pharma 4.0 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Pharma 4.0 Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 18: Latin America Pharma 4.0 Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 19: Latin America Pharma 4.0 Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Pharma 4.0 Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Pharma 4.0 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Pharma 4.0 Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 23: Middle East & Africa Pharma 4.0 Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Pharma 4.0 Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Pharma 4.0 Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Pharma 4.0 Market Value Share, by Technology, 2022
  • Figure 03: Global Pharma 4.0 Market Value Share, by Application, 2022
  • Figure 04: Global Pharma 4.0 Market Value Share, by End-user, 2022
  • Figure 05: Global Pharma 4.0 Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 06: Global Pharma 4.0 Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 07: Global Pharma 4.0 Market Revenue (US$ Mn), by Artificial Intelligence (AI), 2017-2031
  • Figure 08: Global Pharma 4.0 Market Revenue (US$ Mn), by Big Data Analytics, 2017-2031
  • Figure 09: Global Pharma 4.0 Market Revenue (US$ Mn), by Cloud Computing, 2017-2031
  • Figure 10: Global Pharma 4.0 Market Revenue (US$ Mn), by Internet of Things (IoT), 2017-2031
  • Figure 11: Global Pharma 4.0 Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 12: Global Pharma 4.0 Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 13: Global Pharma 4.0 Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 14: Global Pharma 4.0 Market Revenue (US$ Mn), by Drug Discovery and Development, 2017-2031
  • Figure 15: Global Pharma 4.0 Market Revenue (US$ Mn), by Clinical Trials, 2017-2031
  • Figure 16: Global Pharma 4.0 Market Revenue (US$ Mn), by Manufacturing, 2017-2031
  • Figure 17: Global Pharma 4.0 Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 18: Global Pharma 4.0 Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 19: Global Pharma 4.0 Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 20: Global Pharma 4.0 Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017-2031
  • Figure 21: Global Pharma 4.0 Market Revenue (US$ Mn), by Biotechnology Companies, 2017-2031
  • Figure 22: Global Pharma 4.0 Market Revenue (US$ Mn), by CROs and CMOs, 2017-2031
  • Figure 23: Global Pharma 4.0 Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 24: Global Pharma 4.0 Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 25: Global Pharma 4.0 Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Pharma 4.0 Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 27: North America Pharma 4.0 Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 28: North America Pharma 4.0 Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 29: North America Pharma 4.0 Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 30: North America Pharma 4.0 Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 31: North America Pharma 4.0 Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 32: North America Pharma 4.0 Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 33: North America Pharma 4.0 Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 34: North America Pharma 4.0 Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 35: Europe Pharma 4.0 Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 36: Europe Pharma 4.0 Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 37: Europe Pharma 4.0 Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 38: Europe Pharma 4.0 Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 39: Europe Pharma 4.0 Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 40: Europe Pharma 4.0 Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 41: Europe Pharma 4.0 Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 42: Europe Pharma 4.0 Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 43: Europe Pharma 4.0 Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Asia Pacific Pharma 4.0 Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 45: Asia Pacific Pharma 4.0 Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 46: Asia Pacific Pharma 4.0 Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 47: Asia Pacific Pharma 4.0 Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 48: Asia Pacific Pharma 4.0 Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 49: Asia Pacific Pharma 4.0 Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 50: Asia Pacific Pharma 4.0 Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 51: Asia Pacific Pharma 4.0 Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 52: Asia Pacific Pharma 4.0 Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 53: Latin America Pharma 4.0 Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 54: Latin America Pharma 4.0 Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Latin America Pharma 4.0 Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Latin America Pharma 4.0 Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 57: Latin America Pharma 4.0 Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 58: Latin America Pharma 4.0 Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 59: Latin America Pharma 4.0 Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 60: Latin America Pharma 4.0 Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 61: Latin America Pharma 4.0 Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 62: Middle East & Africa Pharma 4.0 Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 63: Middle East & Africa Pharma 4.0 Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 64: Middle East & Africa Pharma 4.0 Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 65: Middle East & Africa Pharma 4.0 Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 66: Middle East & Africa Pharma 4.0 Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 67: Middle East & Africa Pharma 4.0 Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 68: Middle East & Africa Pharma 4.0 Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 69: Middle East & Africa Pharma 4.0 Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 70: Middle East & Africa Pharma 4.0 Market Attractiveness Analysis, by End-user, 2023-2031